MA52957A - Procédés de fabrication de compositions d'acides aminés - Google Patents
Procédés de fabrication de compositions d'acides aminésInfo
- Publication number
- MA52957A MA52957A MA052957A MA52957A MA52957A MA 52957 A MA52957 A MA 52957A MA 052957 A MA052957 A MA 052957A MA 52957 A MA52957 A MA 52957A MA 52957 A MA52957 A MA 52957A
- Authority
- MA
- Morocco
- Prior art keywords
- processes
- manufacturing
- amino acid
- acid compositions
- compositions
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862687725P | 2018-06-20 | 2018-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52957A true MA52957A (fr) | 2021-04-28 |
Family
ID=67226342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052957A MA52957A (fr) | 2018-06-20 | 2019-06-19 | Procédés de fabrication de compositions d'acides aminés |
Country Status (17)
Country | Link |
---|---|
US (1) | US11679089B2 (fr) |
EP (1) | EP3810168A1 (fr) |
JP (1) | JP2021529735A (fr) |
KR (1) | KR20210023846A (fr) |
CN (1) | CN112823018A (fr) |
AR (1) | AR115581A1 (fr) |
AU (1) | AU2019288371A1 (fr) |
BR (1) | BR112020025831A2 (fr) |
CA (1) | CA3099762A1 (fr) |
CL (1) | CL2020003277A1 (fr) |
IL (1) | IL279328A (fr) |
JO (1) | JOP20200323A1 (fr) |
MA (1) | MA52957A (fr) |
MX (1) | MX2020013732A (fr) |
SG (1) | SG11202011611XA (fr) |
TW (1) | TW202015668A (fr) |
WO (1) | WO2019246201A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
CN110678172A (zh) | 2017-04-28 | 2020-01-10 | 胺细拉健康公司 | 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法 |
CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
CA3099762A1 (fr) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Procedes de fabrication de compositions d'acides amines |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
US11737999B2 (en) | 2021-07-26 | 2023-08-29 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871550A (en) * | 1986-09-05 | 1989-10-03 | Millman Phillip L | Nutrient composition for athletes and method of making and using the same |
WO1994014458A1 (fr) | 1992-12-23 | 1994-07-07 | Abbott Laboratories | Aliments a usage medical destines au soutien nutritionnel de nouveaux-nes/de bebes souffrant de maladies metaboliques |
US5922766A (en) * | 1997-07-02 | 1999-07-13 | Acosta; Phyllis J. B. | Palatable elemental medical food |
EP0891719A1 (fr) | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Composition dietique contenant de la methionine |
US20010041187A1 (en) | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
JP4108605B2 (ja) * | 2001-11-13 | 2008-06-25 | 協和醗酵工業株式会社 | アミノ酸含有口腔内速崩壊錠及びその製造方法 |
ATE334998T1 (de) * | 2003-04-07 | 2006-08-15 | Novetide Ltd | Verfahren zur herstellung cyclischer peptide |
US20040213838A1 (en) | 2003-04-24 | 2004-10-28 | Mazer Terrence B. | Medical food tablets containing free amino acids |
CA2552440A1 (fr) | 2003-12-30 | 2005-07-21 | Dr. Reddy's Laboratories Ltd. | Composition pharmaceutique |
US20060073254A1 (en) | 2004-10-04 | 2006-04-06 | Steve Catani | No-carb tabletop sweeteners substitute |
WO2006062238A1 (fr) | 2004-12-07 | 2006-06-15 | Ajinomoto Co., Inc. | Poudre fine d’acide amine et suspension la contenant |
US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
WO2011043647A1 (fr) * | 2009-10-09 | 2011-04-14 | N.V. Nutricia | Composition d'acide aminé avec aptitude à la dispersion améliorée |
JP2012136492A (ja) | 2010-12-25 | 2012-07-19 | Shiga Prefecture Seiyaku Kk | 服用感を改善された漢方内服液剤 |
WO2015002527A1 (fr) * | 2013-07-05 | 2015-01-08 | N.V. Nutricia | Composition d'acides aminés destinée à être utilisée dans le traitement d'un trouble envahissant du développement |
WO2015015149A1 (fr) | 2013-07-31 | 2015-02-05 | Leeds Metropolitan University | Complément alimentaire |
CN107223020A (zh) | 2013-09-25 | 2017-09-29 | 胺细拉健康公司 | 用于预防和治疗糖尿病和肥胖症的组合物和制剂及其产生和用于葡萄糖和卡路里控制的方法 |
US20180125926A1 (en) | 2013-09-25 | 2018-05-10 | Axcella Health Inc. | Compositions and Formulations and Methods of Production and Use Thereof |
FR3032883B1 (fr) * | 2015-02-24 | 2017-03-17 | International Nutrition Res Company | Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques |
JO3543B1 (ar) * | 2015-09-28 | 2020-07-05 | Applied Pharma Res | تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم |
ES2878580T3 (es) * | 2016-02-04 | 2021-11-19 | Czap Res And Development Llc | Vehículos de complejos de inclusión de ciclodextrina estratificados y de liberación controlada |
PL238958B1 (pl) * | 2016-06-29 | 2021-10-25 | Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym |
US20180015122A1 (en) * | 2016-07-14 | 2018-01-18 | Companion Supplements, LLC | Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
JOP20190147A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات |
JP2018154598A (ja) | 2017-03-21 | 2018-10-04 | 株式会社明治 | アミノ酸含有顆粒およびその製造方法 |
CN110678172A (zh) | 2017-04-28 | 2020-01-10 | 胺细拉健康公司 | 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法 |
CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
CA3072092A1 (fr) | 2017-08-14 | 2019-02-21 | Axcella Health Inc. | Acides amines a chaine ramifiee pour le traitement d'une lesion neuronale |
US20190388377A1 (en) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Compositions and methods for the treatment of liver diseases and disorders |
EP3810122A1 (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions et procédés pour la réduction ou le traitement de la résistance à l'insuline et d'états métaboliques |
MA52960A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour la réduction ou le traitement de la fibrose |
CA3101058A1 (fr) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Compositions pour therapie et soin contenant des acides amines ayant un gout amer |
CA3099762A1 (fr) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Procedes de fabrication de compositions d'acides amines |
MA52961A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour la réduction ou le traitement d'une inflammation |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
-
2019
- 2019-06-19 CA CA3099762A patent/CA3099762A1/fr active Pending
- 2019-06-19 CN CN201980054581.8A patent/CN112823018A/zh active Pending
- 2019-06-19 US US16/446,171 patent/US11679089B2/en active Active
- 2019-06-19 WO PCT/US2019/037902 patent/WO2019246201A1/fr active Application Filing
- 2019-06-19 KR KR1020207035956A patent/KR20210023846A/ko unknown
- 2019-06-19 SG SG11202011611XA patent/SG11202011611XA/en unknown
- 2019-06-19 AU AU2019288371A patent/AU2019288371A1/en not_active Abandoned
- 2019-06-19 AR ARP190101694A patent/AR115581A1/es not_active Application Discontinuation
- 2019-06-19 MA MA052957A patent/MA52957A/fr unknown
- 2019-06-19 EP EP19737943.1A patent/EP3810168A1/fr active Pending
- 2019-06-19 BR BR112020025831-8A patent/BR112020025831A2/pt not_active IP Right Cessation
- 2019-06-19 MX MX2020013732A patent/MX2020013732A/es unknown
- 2019-06-19 JP JP2020570677A patent/JP2021529735A/ja active Pending
- 2019-06-20 TW TW108121575A patent/TW202015668A/zh unknown
- 2019-12-20 JO JOP/2020/0323A patent/JOP20200323A1/ar unknown
-
2020
- 2020-12-09 IL IL279328A patent/IL279328A/en unknown
- 2020-12-17 CL CL2020003277A patent/CL2020003277A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2020003277A1 (es) | 2021-07-09 |
EP3810168A1 (fr) | 2021-04-28 |
CA3099762A1 (fr) | 2019-12-26 |
KR20210023846A (ko) | 2021-03-04 |
US20190388374A1 (en) | 2019-12-26 |
MX2020013732A (es) | 2021-02-26 |
AR115581A1 (es) | 2021-02-03 |
US11679089B2 (en) | 2023-06-20 |
JOP20200323A1 (ar) | 2020-12-14 |
JP2021529735A (ja) | 2021-11-04 |
AU2019288371A1 (en) | 2020-12-03 |
SG11202011611XA (en) | 2021-01-28 |
BR112020025831A2 (pt) | 2021-03-23 |
TW202015668A (zh) | 2020-05-01 |
CN112823018A (zh) | 2021-05-18 |
WO2019246201A1 (fr) | 2019-12-26 |
IL279328A (en) | 2021-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52957A (fr) | Procédés de fabrication de compositions d'acides aminés | |
MA49045A (fr) | Compositions et procédés destinés à la distribution régulée d'acide | |
MA51792A (fr) | Procédés de fabrication de lymphocytes t | |
EP3612023A4 (fr) | Procédés de production d'animaux génétiquement modifiés | |
EP3622080C0 (fr) | Procédés améliorés pour la production d'isobutène à partir d'acide 3-méthylcrotonique | |
IL286592B (en) | Amino acid compounds for the treatment of liver disease | |
EP3386550A4 (fr) | Procédés et compositions pour la fabrication et l'utilisation d'acides nucléiques de guidage | |
MA42055A (fr) | Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci | |
EP3751001C0 (fr) | Procédé de fabrication d'ergothionéine | |
MA45290A (fr) | Procédés et compositions d'agents biologiquement actifs | |
EP4013853A4 (fr) | Procédés améliorés de fabrication de compositions organoïdes | |
EP3598537A4 (fr) | Procédé de fabrication de mélange d'électrode et mélange d'électrode | |
EP3924159C0 (fr) | Procédé de fabrication d'ancres ventouses | |
EP3852631A4 (fr) | Procédé d'imagerie | |
EP3455895A4 (fr) | Compositions et procédés pour la fabrication d'électrode | |
IL282114A (en) | Processes for preparing functionalized cyclooctenes | |
MA52417A (fr) | Procédés de modification de composition corporelle | |
EP3316970A4 (fr) | Procédés impliquant la régulation à la baisse de l'apobec3b | |
EP3940821A4 (fr) | Procédé de fabrication d'anode | |
EP3830280A4 (fr) | Procédé de production de nouveaux échafaudages diterpéniques | |
EP3859332A4 (fr) | Procédé de dosage d'hémoglobine glyquée (%) | |
EP3980013A4 (fr) | Procédés de préparation de composés aminopyrimidine | |
MA55282A (fr) | Procédés de fabrication pour la production de compositions d'anticorps anti-tnf | |
MA49791A (fr) | Procédés de fabrication de compositions d'allergènes mixtes | |
MA53391A (fr) | Compositions pour l'agriculture et procédés associés |